CLEVELAND, Nov. 20, 2019 /PRNewswire/ -- ViewRay, Inc.
(NASDAQ: VRAY) today announced that the Company will participate in
the 2019 Piper Jaffray 31st Annual Healthcare Conference
in New York, New York.
Scott Drake, President and CEO, will
give a presentation at 1:30p.m. Eastern Time
on Wednesday, December 4, 2019.
An audio webcast of the Company's presentation will be available
on the investor relations section of ViewRay's website at
www.viewray.com. A replay of the webcast will be available for 7
days after the date of the presentation.
About ViewRay
ViewRay, Inc. (Nasdaq: VRAY), designs,
manufactures and markets the MRIdian® radiation therapy system.
MRIdian is built upon a proprietary high-definition MR imaging
system designed from the ground up to address the unique challenges
and clinical workflow for advanced radiation oncology. Unlike MR
systems used in diagnostic radiology, MRIdian's high-definition MR
was purpose built to address specific challenges, including beam
distortion, skin toxicity, and other concerns that potentially may
arise when high magnetic fields interact with radiation beams.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
ViewRay and MRIdian are registered trademarks of ViewRay,
Inc.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-2019-piper-jaffray-31st-annual-healthcare-conference-300961514.html
SOURCE ViewRay, Inc.